PMC:7696151 / 41501-42051
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1175 | 282-285 | Chemical | denotes | HCQ | MESH:D006886 |
| 1176 | 169-189 | Disease | denotes | rheumatoid arthritis | MESH:D001172 |
| 1177 | 191-210 | Disease | denotes | lupus erythematosus | MESH:D008180 |
| 1178 | 220-238 | Disease | denotes | Sjögren’s syndrome | MESH:D012859 |
| 1179 | 363-420 | Disease | denotes | autoimmune disease-dependent cardiovascular complications | MESH:D002318 |
| 1180 | 487-500 | Disease | denotes | hyperglycemia | MESH:D006943 |
| 1181 | 502-516 | Disease | denotes | hyperlipidemia | MESH:D006949 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T55 | 142-162 | Phenotype | denotes | auto-immune diseases | http://purl.obolibrary.org/obo/HP_0002960 |
| T56 | 169-189 | Phenotype | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/HP_0001370 |
| T57 | 363-381 | Phenotype | denotes | autoimmune disease | http://purl.obolibrary.org/obo/HP_0002960 |
| T58 | 487-500 | Phenotype | denotes | hyperglycemia | http://purl.obolibrary.org/obo/HP_0003074 |
| T59 | 502-516 | Phenotype | denotes | hyperlipidemia | http://purl.obolibrary.org/obo/HP_0003077 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T269 | 0-271 | Sentence | denotes | Most of all, it showed immunosuppressive properties, allowing its employment (alone or in combination) in the first-line treatment of several auto-immune diseases, like rheumatoid arthritis, lupus erythematosus, primary Sjögren’s syndrome, and anti-phospholipid syndrome. |
| T270 | 272-550 | Sentence | denotes | Moreover, HCQ was revealed to be effective in preclinical and clinical trials to dampening autoimmune disease-dependent cardiovascular complications (Figure 7), as well as in the amelioration of disease-independent hyperglycemia, hyperlipidemia, and gastrointestinal complaints. |